Other Global Peers |
SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ALLOGENE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), Lonza (SGX), ARENA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), NANTKWEST INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIELA BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), NUVATION BIO INC (NYSE), MYRIAD GENETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), KURA ONCOLOGY INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), DICERNA PHARMACEUTICALS INC. (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), UNIQURE N.V. (NASDAQ), SHATTUCK LABS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OMEROS CORP (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), POLYNOVO LIMITED (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MESOBLAST LTD (ASX), PLIANT THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), EPIZYME INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INHIBRX INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), COMPUGEN (NASDAQ), RADIUS HEALTH INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MERUS B V (NASDAQ), AGENUS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), ATRECA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ARDELYX INC (NASDAQ), AFFIMED N V (NASDAQ), AKOUOS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), XBIOTECH INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADICET BIO INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), BIOVIE INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVROBIO INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OPTHEA LIMITED (ASX), SESEN BIO INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), VERASTEM INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ANTEOTECH LIMITED (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), IMMUNOME INC (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CABALETTA BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NANOVIRICIDES INC (NYSE American), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), METACRINE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BIONOMICS LTD (ASX), MEDICENNA THERAPEUTICS CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), IBIO INC (NYSE American), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ORGENESIS INC (NASDAQ), CEL-SCI CORP (NYSE American), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), MINERVA NEUROSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), LONGEVERON INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), RECRO PHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SAVARA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), WINDTREE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), MONOPAR THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), ORGANOVO HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), VIRIDIAN THERAPEUTICS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MEMPHASYS LTD (ASX), ACORDA THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ORAGENICS INC (NYSE American), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), BIO-PATH HOLDINGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PATRYS LIMITED (ASX), BIOTRON (ASX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ADALTA LTD (ASX), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), REGENEUS LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX) |